亚太地区无创心输出量监测设备市场预测至 2027 年 - COVID-19 影响和设备区域分析(贴片、手表、探头和导管)、适应症(高血压、冠心病、先天性问题、心肌缺血和梗死、心脏)故障、心律失常等)和最终用户(医院、紧急服务中心、家庭护理等)

Historic Data: 2018-2019   |   Base Year: 2020   |   Forecast Period: 2021-2027


No. of Pages: 133    |    Report Code: TIPRE00022788    |    Category: Life Sciences

Asia Pacific Non-Invasive Cardiac Output Monitoring Device Market

市场介绍

心输出量 (CO) 的测量在医疗实践中至关重要。过去,肺动脉导管 (PAC) 的侵入性监测是测量 CO 的黄金标准,但近年来,已经开发出许多微创或无创设备来测量 CO。心输出量提供有关组织灌注和氧气输送,可以识别死亡或发病风险较高的患者。

 

市场概述与动态

亚太地区无创心输出量监测设备市场预计将从2020年的50,179,390美元增至2027年的72,964,070美元;预计2020年至2027年复合年增长率为5.5%。市场的增长归因于几个关键驱动因素,例如心血管疾病患病率的增加和发展中国家的增长潜力。然而,该设备的高成本阻碍了市场的增长。

近年来,已经开发了许多微创或无创设备来测量心输出量(CO)、这在医疗实践中至关重要。心输出量提供有关组织灌注和氧气输送的信息,并可以识别死亡或发病风险较高的患者。慢性病的患病率正在增加,特别是在印度和中国等发展中国家。此外,心血管疾病的发病率不断上升,主要是由于生活方式的改变以及高吸烟量和不健康饮食等其他因素造成的。因此,心血管疾病的日益流行正在推动无创心输出量监测设备的采用,从而推动亚太地区无创心输出量监测设备市场的增长。发展中国家正在大力发展其医疗保健设施和服务,并正在迈向技术进步。例如,根据商务部和商务部的规定印度工业界、印度政府预计,到 2022 年,医疗保健市场将增长三倍,达到约 1,334.4 亿美元(8.6 万亿印度卢比)。此外,亚太国家的医疗旅游业也在快速增长。因此,发展中国家为非侵入性心输出量监测设备提供商提供了以具有成本效益的产品进入市场的重大机会,这可能会在预测期内推动市场增长。

< p>亚太地区国家预计将面临新冠肺炎 (COVID-19) 疫情带来的巨大挑战。考虑到经济运行和地理条件,疫情对医疗旅游和医疗器械制造产生了不利影响。由于亚太低收入国家医疗基础设施短缺,还引发了其他问题。心脏监测设备是重症监护的一部分,在大流行期间需求量很大。事实证明,非侵入性监测设备有助于监测 COVID-19 患者。不需要住院的患者更喜欢家庭医疗护理,远程医疗设施的日益普及预计将在未来几年支持亚太地区无创心输出量监测设备市场。因此,它可能为市场提供利润丰厚的机会,使经济步入正轨。

 

< span>主要细分市场

根据设备,亚太地区无创心输出量监测设备市场分为贴片、手表、探头和探头。导管。探头和导管细分市场在 2019 年占据最大市场份额。然而,预计手表细分市场在预测期内的复合年增长率最高。

根据迹象,亚太地区无创心输出量监测设备市场细分为高血压、冠心病、先天性疾病、心肌缺血和梗塞、心力衰竭、心律失常等。高血压细分市场在 2019 年占据了最大的市场份额。然而,预计心力衰竭细分市场在预测期内的复合年增长率最高。

基于最终用户方面,亚太地区无创心输出量监测设备市场分为医院、紧急服务中心、家庭护理等。 2019 年,医院细分市场占据最大市场份额。然而,预计紧急服务中心细分市场在预测期内的复合年增长率最高。

  ;

主要来源和列出的公司

一些与本亚太无创心输出量监测设备市场报告相关的主要和次要来源是全印度医学科学研究所 (AIIMS)、中国食品药品监督管理局 (CFDA) 和印度品牌股权基金会 (IBEF) .

 

< strong>购买报告的理由

  • 根据情况确定潜在投资领域对未来几年亚太地区无创心输出量监测设备市场的详细趋势进行分析。
  • 收益深入了解推动支出最高国家不同成瘾治疗药物细分市场需求的根本因素,并确定每个细分市场提供的机会。< /li>
  • 加强您对市场需求驱动因素、行业趋势和最新技术发展等方面的了解。
  • 确定主要领域推动亚太地区无创心输出量监测设备市场的渠道,提供未来机会的清晰画面,有助于分析,从而产生收入
  • 通过关注亚太非侵入性区域内不同国家正在进行的项目来引导资源 心输出量监测设备市场

 

亚太地区非侵入心输出量监测设备市场细分

按设备划分

    < li>补丁
  • 手表
  • 探头和探头导管

按适应症

  • 高血压
  • 冠状动脉疾病
  • 先天性问题
  • 心肌缺血和梗塞
  • 心力衰竭
  • 心律失常
  • 其他

最终用户

  • 医院
  • < span>紧急服务中心
  • 家庭护理
  • 其他

按国家/地区

  • 中国
  • 日本< /li>
  • 印度
  • 澳大利亚
  • 韩国
  • < li>亚太地区其他地区

公司简介

  • 通用电气公司
  • 皇家飞利浦公司
  • 雅培
  • < span>DELTEX MEDICAL
  • CONMED Corporation
  • NIMedical
  • 百特国际公司


Asia Pacific Non-Invasive Cardiac Output Monitoring Device Strategic Insights

Strategic insights for Asia Pacific Non-Invasive Cardiac Output Monitoring Device involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-non-invasive-cardiac-output-monitoring-device-market-strategic-framework.webp
Get more information on this report

Asia Pacific Non-Invasive Cardiac Output Monitoring Device Report Scope

Report Attribute Details
Market size in 2020 US$ 50,179.39 thousand
Market Size by 2027 US$ 72,964.07 thousand
Global CAGR (2020 - 2027) 5.5%
Historical Data 2018-2019
Forecast period 2021-2027
Segments Covered By 设备
  • 贴片
  • 手表
  • 探针和导管
By 适应症
  • 高血压
  • 冠心病
  • 先天性疾病
  • 心肌缺血及梗塞
  • 心脏衰竭
  • 心律失常
By 最终用户
  • 医院
  • 急救中心
  • 家庭护理
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • General Electric Company
  • Koninklijke Philips N.V.
  • Abbott
  • DELTEX MEDICAL
  • CONMED Corporation
  • NIMedical
  • Baxter International Inc.
  • Get more information on this report

    Asia Pacific Non-Invasive Cardiac Output Monitoring Device Regional Insights

    The regional scope of Asia Pacific Non-Invasive Cardiac Output Monitoring Device refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-non-invasive-cardiac-output-monitoring-device-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Non-Invasive Cardiac Output Monitoring Device Market

    1. General Electric Company
    2. Koninklijke Philips N.V.
    3. Abbott
    4. DELTEX MEDICAL
    5. CONMED Corporation
    6. NIMedical
    7. Baxter International Inc.
    Frequently Asked Questions
    How big is the Asia Pacific Non-Invasive Cardiac Output Monitoring Device Market?

    The Asia Pacific Non-Invasive Cardiac Output Monitoring Device Market is valued at US$ 50,179.39 thousand in 2020, it is projected to reach US$ 72,964.07 thousand by 2027.

    What is the CAGR for Asia Pacific Non-Invasive Cardiac Output Monitoring Device Market by (2020 - 2027)?

    As per our report Asia Pacific Non-Invasive Cardiac Output Monitoring Device Market, the market size is valued at US$ 50,179.39 thousand in 2020, projecting it to reach US$ 72,964.07 thousand by 2027. This translates to a CAGR of approximately 5.5% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Non-Invasive Cardiac Output Monitoring Device Market report typically cover these key segments-

  • 设备 (贴片, 手表, 探针和导管)
  • 适应症 (高血压, 冠心病, 先天性疾病, 心肌缺血及梗塞, 心脏衰竭, 心律失常)
  • 最终用户 (医院, 急救中心, 家庭护理)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Non-Invasive Cardiac Output Monitoring Device Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Non-Invasive Cardiac Output Monitoring Device Market report:

  • Historic Period : 2018-2019
  • Base Year : 2020
  • Forecast Period : 2021-2027
  • Who are the major players in Asia Pacific Non-Invasive Cardiac Output Monitoring Device Market?

    The Asia Pacific Non-Invasive Cardiac Output Monitoring Device Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • General Electric Company
  • Koninklijke Philips N.V.
  • Abbott
  • DELTEX MEDICAL
  • CONMED Corporation
  • NIMedical
  • Baxter International Inc.
  • Who should buy this report?

    The Asia Pacific Non-Invasive Cardiac Output Monitoring Device Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Non-Invasive Cardiac Output Monitoring Device Market value chain can benefit from the information contained in a comprehensive market report.